Gender-specific issues in liver and kidney failure and transplantation: A review

Journal of Women's Health

Volumn 14, Issue 7, 2005, Pages 617-626

  Sanfey, Hilary ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; ESTROGEN; ESTROGEN RECEPTOR; FOLLITROPIN; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LUTEINIZING HORMONE; PREDNISONE; TAMOXIFEN;

CLINICAL FEATURE; COMORBIDITY; CONGENITAL MALFORMATION; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG METABOLISM; ESTROGEN THERAPY; FEMALE INFERTILITY; GRAFT SURVIVAL; HELLP SYNDROME; HEMODIALYSIS; HIGH RISK PREGNANCY; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER METABOLISM; LIVER TOXICITY; LIVER TRANSPLANTATION; LOW DRUG DOSE; NONHUMAN; OBSTRUCTIVE JAUNDICE; OPPORTUNISTIC INFECTION; ORGAN DONOR; PATHOGENESIS; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SMALL FOR DATE INFANT; TREATMENT OUTCOME;

ANIMALS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; LIVING DONORS; MALE; SEX FACTORS; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 27144551371     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2005.14.617     Document Type: Review

References (98)

1. Legato MJ. Preface. In: Principles of gender-specific Medicine. Oxford: Elsevier Academic Press, 2004:xv.
2. Legato MJ, ed. Immunology. In: Gender-specific aspects of human biology for the practicing physician. Armonk, NY: Futura Publishing Company, 1997.
3. Lahita RG. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26:951.
4. Sthoeger ZM, Chiorazzi N, Lahita RG. Regulation of the immune response by sex hormones. I. In vivo effects of estradiol and testosterone on pokeweed mitogen-induced B-cell differentiation. J Immunol 1988;141:91.
5. Kanda N, Tsuchida T, Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1703.
6. George ED, Schluger LK. Special women's health issues in hepatobiliary diseases. Clin Fam Pract 2000;2:155.
7. Dourakis SP, Tolis G. Sex hormonal preparations and the liver. Eur J Contracept Reprod Health Care 1998;3:7.
8. Brenner PF. Differential diagnosis of abnormal uterine bleeding. Am J Obstet Gynecol 1996;175:766.
9. Bacq Y, Zarka O, Brechot JF, et al. Liver function tests in normal pregnancy: A prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996;23:1030.
10. Castro MA, Fassett MJ, Reynolds TB, Shaw KJ, Goodwin TM. Reversible peripartum liver failure: A new prospective on the diagnosis, treatment and cause of acute liver failure of pregnancy based on 28 consecutive cases. Am J Obstet Gynecol 1999;181:389.
11. Reyes H. Acute fatty liver of pregnancy. A cryptic disease threatening mother and child. Clin Liver Dis 1999;3:69.
12. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatoxicity. Pharmacol Ther 1995;67:101.
13. Burroughs AK, Seong NGH, Dojcinov DM, et al. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 1982;204:481.
14. Reyes H, Sandoval L, Wainstein A, et al. Acute fatty liver of pregnancy: A clinical study of 12 episodes in 11 patients. Gut 1994;35:101.
15. Barton CH, Mirahmadi MK, Vaziri ND. Effects of long-term testosterone administration on pituitary-testicular axis in end-stage renal failure. Nephron 1982;31:61.
16. MacLean MA, Cameron AD, Cumming GP, et al. Recurrence of acute fatty liver of pregnancy. Br J Obstet Gynaecol 1994;101:453.
17. Visconti M, Manes G, Giannattasio F, Uomo G. Recurrence of acute fatty liver of pregnancy. J Clin Gastroenterol 1995;21:243.
18. Misra S, Sanyal AJ. Pregnancy in a patient with portal hypertension. Clin Liver Dis 1999;3:147.
19. Van Asche FA, Spitz B. Thromboxane synthetase inhibition in pregnancy-induced hypertension. Am J Obstet Gynecol 1998;159:1015.
20. Gordon SC. Pregnancy and liver disease. Budd-Chiari and infarct in pregnancy. Clin Liver Dis 1999;3:97.
21. De Stefano V, Leone G, Mastrangelo S. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C and protein S. Thromb Haemost 1994;71:799.
22. Vons C, Smadja C, Franco D, et al. Successful pregnancy after Budd-Chiari syndrome. Lancet 1984; 2:975.
23. Walcott WO, Derick DE, Jolley JJ, et al. Successful pregnancy in a liver transplant patient. Am J Obstet Gynecol 1978;132:340.
24. Goodrich MA, James EM, Baldus WP, et al. Portal vein thrombosis associated with pregnancy. J Reprod Med 1993;38:969.
25. Schweitzer IL, Peters RL. Pregnancy in hepatitis B antigen positive cirrhosis. Obstet Gynecol 1976; 48:535.
26. Sweet RL. Hepatitis B infection in pregnancy. Obstet Gynecol Report 1990;2:128.
27. Arevalo JA. Hepatitis B in pregnancy. West J Med 1989;150:668.
28. Jurema MW, Polaneczky M, Ledger WJ. Hepatitis B immunization in postpartum women. Am J Obstet Gynecol 2001;185:355.
29. Ishikawa I, Maeda K, Nakai S, Kawaguchi Y. Gender differences in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000; 35:1072-1075.
30. Tierney WM, McDonald CJ, Luft FC. Renal disease in hypertensive adults: Effect of race and type II diabetes mellitus. Am J Kidney Dis 1989;13:485.
31. Coggins CH, Lewis JB, Caggiula AW, et al. Differences between women and men with chronic renal disease. Nephrol Dial Transplant 1998;13:1430.
32. Schrander-VD, Meer AM, van Saase JLCM, Roodvoets AP, van Dorp WT. Mortality in patients receiving renal replacement therapy, a single-center study. Clin Nephrol 1995;43:174.
33. Neugarten J, Silbiger SR. The impact of gender on renal transplantation. Transplantation 1994;58:1145.
34. Kochakian CD. Regulation of kidney growth by androgens. Adv Steroid Biochem Pharmacol 1977;6:1.
35. Meier-Kriesche H, Ojo A, Leavey S, et al. Gender differences in the risk for chronic renal allograft failure. Transplantation 2001;71:429.
36. Negulescu O, Bognar I, Lei J, Devarajan P, Silbiger S, Neugarten J. Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. Kidney Int 2002;62:1989.
37. Simon P, Ramee MP, Autuly V, et al. Epidemiology of primary glomerular diseases in a French region: Variations according to period and age. Kidney Int 1994;46:1192.
38. Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1994;25:515.
39. Chapel TA, Burns RE. Oral contraceptives and exacerbations of SLE. Am J Obstet Gynecol 1971;110:366.
40. Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1997; 40:797.
41. Rose E, Pillsbury DM. Lupus erythematosus (erythematodes) and ovarian function: Observations on a possible relationship with a report of six cases. Ann Intern Med 1944;21:1022.
42. Lahita RG. Sex steroids and SLE: Metabolism of androgens to estrogens [Editorial]. Lupus 1992;1:125.
43. Jungers P, Nahoul K, Pelissier C. Low plasma androgens in women with active or quiescent SLE. Arthritis Rheum 1982;25:454.
44. Buyon JP. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus. J Am Wom Med Assoc 1998;53:13.
45. Kausz AT, Obrador GT, Arora P, et al. Late initiation of dialysis among women and ethnic minorities in the united states. J Am Soc Nephrol 2000;11:2351.
46. Bloembergen WE, Young EW, Woods JD, et al. Factors associated with late referral among new dialysis patients in the US. J Am Soc Nephrol 1997;8:186A (Abstract).
47. U.S. Renal Data System: USRDS Annual Data Report. The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2000.
48. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. Causes of death in dialysis patients: Racial and gender differences. J Am Soc Nephrol 1994;5:1231.
49. Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 1997;29:685.
50. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999;33:235.
51. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996;50:235.
52. Bloembergen WE, Port FK, Mauger EA, Briggs JP, Leichtman AB. Gender discrepancies in living related renal transplant donors and recipients. J Am Soc Nephrol 1996;7:1139.
53. Pirsh JD, D'Alessandro AM, Sollinger HW, et al. Living-unrelated renal transplantation at the University of Wisconsin. Clin Transplant 1990;xx:241.
54. Sesso R, Klag MJ, Ancao MS, et al. Kidney transplantation from living unrelated donors. Ann Intern Med 1992;117:983.
55. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995;333:333.
56. Zimmerman D, Donnelly S, Miller J, Stewart D, Albert SE. Gender disparity in living renal transplant donation. Am J Kidney Dis 2000;36:534.
57. Karlson EW, Daltroy LH, Liang MK, Eaton HE, Katz JN. Gender differences in patient preferences may underlie differential utilization of elective surgery. Am J Med 1997;102:524.
58. Aaronson KD, Schwartz JS, Goin JE, Mancin DM. Sex differences in patient acceptance of cardiac transplant candidacy. Circulation 1995;91:2753.
59. Simmons RG, Klein SD. Gift of life: The social and psychological impact of organ transplantation. New York: Wiley, 1977.
60. Marino IR, Doyle HR, Aldrighetti L, Doria C, McMichael J. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22:1754.
61. Rustgi VK, Marino G, Halpern MT, et al. Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transplant 2002;8:514.
62. Zeier M, Dohler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol 2002; 13:2570.
63. Candinas D, Gunson BK, Nightingale P, et al. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1985;346:1117.
64. Kahn D, Gavaler JS, Makowka L, Van Thiel DH. Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci 1993;38:148514.
65. Kouli F. Impact of donor/recipient traits independent of rejection on long-term renal function. Am J Kidney Dis 2001;37:356.
66. Kasiske BL, Umen J A. The influence of age, sex, race and body habitus on kidney weight in humans. Arch Pathol Lab Med 1986;110:55.
67. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992;3:162.
68. MacKenzie HS, Azuma H, Rennke HG, Tilney NL, Brenner BM. Renal mass as a determinant of late allograft outcome: Insights from experimental studies in rats. Kidney Int 1995;52:S38.
69. Taal MW, Tilney NL, Brenner BM, MacKenzie HS. Renal mass: An important determinant of late allograft outcome. Transplant Rev 1998;12:74.
70. Panatjotopoulos N, Ianhez LE, Neumann J, Sabbaga E, Kalil J. Immunological tolerance in human transplantation. The possible existence of a maternal effect. Transplantation 1990;50:443.
71. Shibue T, Kondo K, Iwaki Y, Terasaki PI. Effect of sex on kidney transplants. In: Terasaki PI, ed. Clinical transplants 1987. Los Angeles: UCLA Tissue Typing Laboratory, 1987:351.
72. Koka P, Cecka JM. Sex and age effects in renal transplantation. In: Terasaki PI, ed. Clinical transplants 1990. Los Angeles: UCLA Tissue Typing Laboratory, 1990:437.
73. Briscoe DM, Sayegh MH. A rendezvous before rejection: Where do T-cells meet transplant antigens? Nat Med 2002;8:220.
74. Somjen D, Kohen F, Jaffe A, Amir-Zaltsman Y, Knoll E, Stern N. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 1998;32:39.
75. McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999;99:2317.
76. Michet CJJ, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105.
77. Scantlebury V, Gordon R, Tzakis A, et al. Childbearing after liver transplantation. Transplantation 1990; 49:317.
78. Radomski JS, Moritz MJ, Munoz SJ, et al. National transplantation registry: Analysis of pregnancy outcome in female liver transplant recipients. Liver Transplant Surg 1995;1:281.
79. Jain A, Venkataramanan R, Fung JJ, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997;64:559.
80. Molmenti EP, Jain AB, Marino N, et al. Pregnancy and liver disease: Liver transplantation and pregnancy. Clin Liver Dis 1999;3:163.
81. Rizzoni G, Ehrich JHH, Broyer M, et al. Successful pregnancies in women on renal replacement therapy: Report from the EDTA Registry. Nephrol Dial Transplant 1992;7:279.
82. Cohen D, Galbraith C. General health management and long-term care of the renal transplant recipient. Am J Kidney Dis 2001;38:S10.
83. Ville Y, Fernandez H, Samuel D, Bismuth H, Frydman R. Pregnancy in liver transplant recipients: Course and outcome in 19 cases. Am J Obstet Gynecol 1993;168:896.
84. Kainz A. Analysis of 100 pregnancy outcomes in women treated systemically with tacroloimus. Transplant Int 2000;13:S299.
85. Lamarque V, Leleu MF, Monka C, Krupp P. Analysis of 629 pregnancy outcomes in transplant recipients treated with sandimmun. Transplant Proc 1997;29: 2480.
86. Hricik DE, Halbert RJ, Barr ML, et al. Life satisfaction in renal transplant recipients: Preliminary results from the Transplant Learning Center. Am J Kidney Dis 2001;38:580.
87. Sutton TD, Murphy SP. Stressors and patterns of coping in renal transplant patients. Nurs Res 1989;38:46.
88. Fallon M, Gould D, Wainwright SP. Stress and quality of life in the renal transplant patient: A preliminary investigation. J Adv Nurs 1997;25:562.
89. Pinson CW, Feurer ID, Payne JL, et al. Health-related quality of life after different types of solid organ transplantation. Ann Surg 2000;232:597.
90. Chertow GM, Zenios SA. Gridlock on the road to kidney transplantation Am J Kidney Dis 2001;37:435.
91. Wolfe RA, Ashby VB, Milford EL, et al. Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis 2000;36:1025.
92. Bloembergen WE, Mauger EA, Wolfe RA, Port FK. Association of gender and access to cadaveric renal transplantation. Am J Kidney Dis 1997;30:733.
93. Bloembergen WE, Young EW, Woods JD, et al. Factors associated with late referral among new dialysis patients in the US. J Am Nephrol Soc 1997;8:186A.
94. Soucie JM, Neylan JF, McClellan W. Race and sex differences in the identification of candidates for renal transplantation. Am J Kidney Dis 1992;19:414.
95. Arora P, Obrador GT, Ruthazer R, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 1999;10:1281.
96. Kasiske BL, London W, Ellison MD. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol 1998;9:2142.
97. Alexander GC, Sehgal AR. Why hemodialysis patients fail to complete the transplantation process. Am J Kidney Dis 2001;37:321.
98. Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 1998;280:1148.